All Posts: breast cancer
-
Lombardi Women Celebrate Breast Cancer Patients and Researchers
From its humble beginnings 18 years ago with a group of women at the Palm restaurant in Tysons Corner, Lombardi Women: Connecting for a Cure has grown into a fundraising powerhouse, netting more than $5 million in donations for breast cancer research at Georgetown University’s Lombardi Comprehensive Cancer Center. This year’s event was held September 26.
Category: Lombardi Stories
-
ISPY2: A Unique, Flexible Breast Cancer Trial for Modern Times
The ISPY2 breast cancer clinical trial is a unique phase 2 study that offers a broad range of treatment options for patients with locally advanced breast cancer.
Category: Lombardi Stories
-
New Study: Analysis Supports New Recommendation to Begin Mammogram Screening at 40
Georgetown Lombardi’s Jeanne Mandelblatt, MD, MPH, and Amy Trentham-Dietz, PhD, of University of Wisconsin Carbone Cancer Center, were lead authors of a study informing the updated final recommendation of the United States Preventive Services Task Force regarding breast cancer screening, released April 30
Category: News Release
-
The Aspirin Conundrum: Navigating Negative Results, Age, Aging Dynamics and Equity
A new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications for cancer and other disease intervention trials, say researchers from Georgetown University’s Lombardi Comprehensive Cancer Center. They outline their concerns in an editorial accompanying the study’s findings published April 29 in the JAMA.
Category: News Release
-
Lombardi Women Event Rallies Support for Breast Cancer Research
The 17th Annual Lombardi Women event brought together nearly 400 of the Washington area’s most influential women in support of Georgetown University’s Lombardi Comprehensive Cancer Center and its Nina Hyde Center for Breast Cancer Research.
Category: Lombardi Stories
-
Biology Behind New Drug Used to Treat Triple-Negative Breast Cancer Uncovered
How TTP488 (azeliragon), an experimental drug, impairs aggressive, triple-negative breast cancer from metastasizing has been uncovered at the cellular level, according to researchers at Georgetown University’s Lombardi Comprehensive Cancer Center.
Category: News Release
-
Research To Help Patients Make Informed Decisions About Breast MRI
While many people think that breast cancer screening and mammography are synonymous, Claire Conley, PhD, wants people to know that women who are at higher than average risk for breast cancer may also receive a breast MRI.
Category: Lombardi Stories
-
Women with Elevated Breast Cancer Risk Could See Mortality Benefit from Estrogen-Blocking Drugs
WASHINGTON (Thursday, December 1, 2022) — While it has long been recognized that drugs that block the cancer-promoting activity of estrogen reduce the risk of developing new breast cancers, a new computer modeling study led by researchers at Georgetown Lombardi Comprehensive Cancer Center and colleagues showed that these treatments could also reduce the risk of […]
Category: News Release
-
Study in Mice Suggests that Expression of Estrogen-Related Gene Can Impact Postmenopausal Breast Cancer Risk and Prevention Strategies
WASHINGTON (December 1, 2022) — In a study using a first-of-its-kind mouse model of aging that mimics breast cancer development in estrogen receptor-positive postmenopausal women, investigators at Georgetown Lombardi Comprehensive Cancer Center and colleagues have determined that over-expression, or switching on, of the Esr1 gene could lead to elevated risk of developing estrogen receptor-positive breast […]
Category: News Release
-
‘Lombardi Women’ Event Brings Together Local Businesswomen to Support Breast Cancer Research
(October 7, 2022) — Held in person for the first time since 2019, the 16th Annual Lombardi Women event brought together 450 businesswomen and 43 sponsoring companies from across the Washington area. The event took place October 6 at the Pavilions at Wolf Trap National Park. “For 16 years, this group of women has come […]
Category: Lombardi Stories